













































































































Severe intellectual disability, microphthalmia, growth retardation, bisuspic aortic valve
No phenotype reported in Decipher 
Genes involved Duplicated enhancers Other chromosomal abnormalities / Comments References 
P505 Male Moderate non-syndromic intellectual disability Familial GAIN of 41 kb chrX:24992914 – 25033979 
Global Gender Clinical description Inheritance Gain Variant coordinates (hg19) and size 
ARX hs8a, hs8b, hs9 ARX copy non-functional Whibley et al 2010 
P1 Male Mild intellectual disability, speech delay and hypotonia Familial GAIN of 0.4 Mb chrX:24887676 - 25325777 ARX, POLA1 hs2, hs8a, hs8b, hs9 - This study 
P2 Female Learning difficulties Familial (Mother of P1) GAIN of 0.4 Mb chrX:24887676 - 25325777 ARX, POLA1 hs2, hs8a, hs8b, hs9 - This study 
P3 Male Developmental delay, growth retardation, delayed speech Familial GAIN of 0.377 Mb chrX: 24677441- 25054698 ARX, POLA1, hs2, hs8a, hs8b, hs9 
GAIN of Xp11.4 region spanning a min 0.071 Mb and max 0.161 Mb. Duplicates 
part of TSPAN7 gene, familial, unclear clinical significance. This study 
P4 Female Short stature and speech delay Familial (Sister of P3) Gain of 0.377 Mb chrX: 24677441- 25054698 ARX, POLA1, hs2, hs8a, hs8b, hs9 This study 
Decipher 253498 DP1 Male Familial Gain of 0.45 Mb chrX:24593306- 25033815 ARX, POLA1, PCYT1B hs2, hs8a, hs8b, hs9 ARX copy non-functional 




Autism, hyperactivity, delayed speech and language development, ADHD, other physical 
abnormalities unknown GAIN of 0.58 Mb 
chrX:24650157 - 
25230368 ARX, POLA1, PCYTB1 hs2, hs8a, hs8b, hs9 - 
Popovici et al 2014 
(P4) 
Decipher 266096 DP3 Male Generalized hypotonia, Microcephaly, other physical abnormalities unknown GAIN of 0.81 Mb chrX:24741372- 25554818 ARX, POLA1 




Delayed speech and language development, psychiatric abnormalities, Hyperactivity, 
Intellectual disability, Dysarthria De novo GAIN of 0.72 Mb 
chrX:24815107 - 
25542728 ARX, POLA1 
hs2, hs8a, hs8b, hs9, 
hs13 
GAIN of Xq25 of 0.41 Mb including STAG2 and XIAP – inherited from normal 
parent- unknown pathogenicity. 
Popovici et al 2014 
(P5) 
Decipher P277835 
DP5 Male Moderate intellectual disability Familial GAIN of 0.3 Mb 
chrX:24861601 - 
25163763 ARX, POLA1 hs2, hs8a, hs8b, hs9 - 





GAIN of 3q11.1q11.2 of 0.929, incl. PROS1 and ARL13B. No clear clinical 
relevance for duplication of these genes. GAIN 4q35.2 of 0.597 Mb; GAIN 11.2q12 
of 0.439 Mb. No disease associated with gains. 
This study 
Decipher P267095 



















HCNE ID Coordinate (hg19) Length (bp) Forward Primer Reverse Primer Vista Enhancer Browser Other References
Visel et al., 2013 (mouse) Expression Features Tested Sequences Expression Features
ARX_hs1 chrX:24,822,379-24,824,163 1785 AATGTTCATCAAGTGAGAGA CCACATAAATGTTCTAGAAG hs116 negative
ARX_hs2 chrX:24,894,335-24,896,084 1750 AGCAAGCATATGCATTTCAACAG TTTTGAGAATTGATTTTTCAGGTG hs118 midbrain
ARX_hs3 chrX:24,915,382-24,918,272 2891 GTGGACTTTGGGAGGAAAACAG ATTTGAGCAGAAAACAACTCCTG hs119 forebrain 
ARX_hs4 chrX:24,945,475-24,947,567 2093 AAAACGGTGGTATTAAAGCATT ATGTTACCAGTTTCTCCCTTGCT hs120 negative
   ARX_hs4S chrX:24,946,225-24,946,965 741 GCAAAATATGTCAGGAATCA CTACAATATGCATCATCATTA
   ARX_hs4L chrX:24,945,320-24,949,744 4425 GGACCTCATCAGAAATCTCA GCTGTGGAGATAGCTCAAGT
ARX_hs5 chrX:24,984,230-24,986,251 2022 AGTTTTCATTTGAAAAACTAGCA CTGCCACCATGGTACACTGA N.A. N.A.
ARX_hs6 chrX:24,998,179-25,000,979 2801 TTTCTCTGTTGTATGCATTAAT AATTTTAAAATATGGCTCACTC N.A. N.A.
Colasante et al., 2008 (mouse)
ARX_hs7 chrX:25,007,981-25,010,746 2766 GTTGAAGGTCAACATTTTGT AGGCAAAGACATTTTAACAT hs121 forebrain UAS3 (0.8kb; mm9 - ChrX:90,555,532–90,556,342)
   ARX_hs7S chrX:25,007,879-25,009,581 1703 GTGGGTGATGAACATGTTTTCTG AAAGCAATGTAAAGAATGCCACT
ARX_hs8 chrX:25,017,067-25,020,264 3198 TGGAGTTAATCTTGTGACTGTTGC ACTCCGTTCCCGGGTTTAGTA N.A. forebrain, eye, midbrain
UAS1- UAS2
(3.5kb; approximately 1.5kb downstream of Arx)
cx, eminentia thalami (et), vt, hy
   ARX_hs8a chrX:25,017,067-25,018,756 1690 TGGAGTTAATCTTGTGACTGTTGC TGTGATCTTACTAGAGTGACAAAAGG hs122 forebrain UAS2  (0.3kb; mm9 - ChrX: 90,548,333–90,548,660)
   ARX_hs8b chrX:25,018,992-25,020,264 1273 CTAAGATGCCCGCCCTGACTA ACTCCGTTCCCGGGTTTAGTA hs145 eye, forebrain, midbrain UAS1 ( 0.65kb; mm9 - ChrX: 90,546,954 –90,547,604)
ARX_hs9 chrX:25,026,079-25,028,244 2166 ACTGCATATCAGCTATTTTCA AAGTAGACCCAAGCACTCTCTCA N.A. N.A.
ARX_hs10 chrX:25,067,479-25,069,064 1586 TGAGCAGAGAGCAGCAGTTCAT TACTGAGACTGTTACATTTTC N.A. N.A.
ARX_hs11 chrX:25,037,049-25,038,881 1833 CTGGCTCCTCTAATCTTTGG AGAAAGCAGATGGTGGTGAT N.A. N.A.
ARX_hs12 chrX:25,212,479-25,213,879 1401 GCTAAGGTAGAGTAAGCAGT TGTAAAAGGTGAAGCAGTGT N.A. N.A.
ARX_hs13 chrX:25,400,224-25,402,334 2111 TGGAAACATTAAACAATTCAAGA CTTACCATTTGTGGACTTTGCTT hs123 forebrain
ARX_hs14 chrX:24,286,833-24,288,865 2033 CCAGAAAATGGAAGCAACAG AGGAATACTTCTTTCTGAGG N.A. N.A.
ARX_hs15 chrX:25,197,539-25,199,079 1541 AGGTTAGAATCAGTCAGGTA CAAAGTTTCATCTTTAGCCA N.A. N.A.
ARX_hs16 chrX:25,667,129-25,669,025 1897 ACATGCGTTCAACTGTTTTA TTATTTGCTGAGTTCATGAT N.A. N.A.
ARX_hs17 chrX:24,828,086-24,828,739 654 CATAACTGGTAACGTTTTTGTA AATTACAGGCTCCACAGACT N.A. N.A.
ARX_hs18 chrX:24,860,129-24,861,126 998 CTCTTACTTGAATGTGCTTG AAATGAAGTGTATTGGGGGA N.A. N.A.
ARX_hs19 chrX:24,880,537-24,881,987 1451 CTTAAGCCTTTCAATGACTT GTAACACTGAACATAGGTAT N.A. N.A.
ARX_hs20 chrX:24,883,965-24,885,114 1150 ATGAGGTGTATTTATTCTCA CAATTAGCTTACGATCTATA N.A. N.A.
ARX_hs21 chrX:24,902,120-24,903,573 1454 GATCAATCAGAGTGAACTTAT GCTGACAGCAAGAACAGGTA N.A. N.A.
ARX_hs22 chrX:24,941,098-24,942,121 1024 GACATTAGGTTAACCTAGA ATATGCCTTCGAATTCCAGT N.A. N.A.
ARX_hs23 chrX:24,961,145-24,962,651 1507 CTCTCCACTCTCCACTGTAAC ATTTCAGGTTGAAAGAAGGA N.A. N.A.
ARX_hs24 chrX:24,972,050-24,973,102 1053 TCTGCTAAGCAGCTGCTAGA CTCACAAATGTCCATGCTCCTA N.A. N.A.
ARX_hs25RI chrX:25,020,182-25,021,940 1759 GGAGTCTGAGGGTTTTAGACT GCTTCCGAAACCTTCAAGAT hs145 eye, forebrain, midbrain  (Rada-Iglesias et al., 2011) Not tested
ARX_hs26RI chrX:25,196,624-25,197,659 1036 GCCTGGGTCCTAGCTAAGAAAT CTGTGAGCAGATATTCCAGTA N.A. N.A.  (Rada-Iglesias et al., 2011) Not tested
not tested
Cerebral cortex (cx),ventral and 
dorsal pallium, ganglionic eminences 
(ge), ventral thalamus (vt), 
hypothalamus (hy). Active also adult.
46
Supplementary table 1
Suppl. Table 1 (separate Excel document) List of all tested sequences and 
enhancer testing analysis. The coordinates of tested sequences relate to the human 
genome (hg19). Some elements were tested in different sizes. According to their 
function in the reporter gene assays, they were evaluated for reproducible, partially 
reproducible and inconsistent activity. References are given for similar human 
elements and for orthologous mouse sequences that have been tested in the mouse 
previously. 
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Suppl. Fig. 1  arxa in situ hybridization pattern in zebrafish. 
a. Arx expression pattern characterization in 3 dpf embryos by in situ hybridization.
Expression domains are labeled with color-coded arrows explained in C. b. Series of 
transverse sections through wildtype embryonic brain. Note that predominantly 
GABAergic forebrain regions such as the subpallium (Sd, Sv), the preoptic region 
(Po), the ventral thalamus (VT), the hypothalamus (Hy), and the ventral posterior 
tuberculum (PTv) show strongest arx expression. Predominantly glutatamatergic 
regions such as the pallium (P) and the thalamic eminence (EmT) showed weaker arx 
expression, whereas both the habenula (Ha) and the dorsal thalamus (DT) remained 
completely unstained. Asterisks are at the position of the olfactory epithelium.  
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Suppl. Fig. 2  ARX_enhancer:GFP and arxa mRNA colabeling. 
a. arx in situ hybridization pattern as revealed by BCIP/NBT staining. b. arxa mRNA
distribution compared to GFP localization in ARX-enhancer transgenic embryos at 3 
dpf by double staining analysis. Note that the fluorescent in situ hybridization signals 
are weaker than compared to BCIP/NBT stains and therefore the expression domains 
appear smaller. Representative optical sections of confocal scans performed 
horizontally through the embryos are shown for each enhancer. Arrows point to 
regions in which arx mRNA and GFP overlap, in a color-code that corresponds to the 
initial expression pattern description in Figure 1 (purple: pallium, green: ventral 
thalamus). hs2: GFP/arxa mRNA overlap in the floorplate, in the dorsolateral region 
of the ventral thalamus and in the medial and dorsal telencephalon, although in some 
telencephalic areas seem to exclude the proliferative zone. hs8b: GFP/arxa mRNA 
overlap in the ventral thalamus. hs13: the GFP/arxa mRNA overlap in the dorsal 
telencephalon. This becomes more obvious at later stages when hs13 regulated GFP 
becomes more confined to the dorsomedial telencephalon. hs8a: GFP overlapped 
arxa mRNA only in the dorsal telencephalon where arxa is weakly expressed, most of 
the GFP signal further ventral appears ectopic. 
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Suppl. Fig. 3  Projections of ARX neurons.  
Representative images of hs8b and hs8a enhancer transgenic lines that were confocal 
imaged at 6 dpf. The focus is on neuronal projections to identify neuronal populations 
in which human ARX and zebrafish arx genes are active. The arrows point to 
projections originating from the ventral thalamus, which is hs8b regulated domain, 
and follow a color code: (orange) neuronal fibers originating dorsolateral and 
projecting posterior; (blue) fibers originating medial and projecting dorsal into the 
tectum; (grey) fibers originating medial and projecting dorsolateral; (pink) projections 
appearing at 6 dpf that grow anteriorly into the telencephalon. The white arrow labels 
the habenular commissure.  
a to c: Scans of dorsally oriented hs8b:GFP embryos at 3 dpf. a. Optical sections of 
GFP (green) versus acetylated tubulin (red) antibody stained embryos at the level of 
the optic tectum. b.  Optical sections of a live imaged embryo on two different levels 
through the ventral thalamus – the left image has focus on the dorsal region, whereas 
focus in the right image is on the medial region. c. 3D projection from a different live 
imaged embryo and shows a magnification of a 45° rotation in the 2nd image. This 
perspective makes obvious that the fiber bundles projecting posteriorly are originating 
dorsolateral, whereas the projections leading into the tectum and dorsolateral originate 
further ventral and medial. d. Lateral scan of a 3 dpf anti-GFP stained embryo with 
view on the ventral thalamus (eyes removed). The projections had been computer 
tracked and are shown in different rotations (angle of views are indicated in the 
image). e. hs8b:Gal4-UAS:Kaede embryos were imaged at 6 dpf. Optical sections of a 
horizontally performed scan shown from dorsal to ventral. The habenular commissure 
connecting the habenular nuclei on both sides of the diencephalon is strongly labeled 
at 6 dpf. The optic tectum is innervated by fibers originating in the ventral thalamus. 
Labeled ventral thalamic fibers have increased at this stage. Visible now are fine 
fibers that grow anteriorly into the telencephalon (pink arrows).  
f to h: Confocal scans of GFP-expressing 6-dpf-larvae of hs8a enhancer regulated 
Gal4-UAS:GFP transgenic line in three orientations. f. Optical sections through the 
dorsal telencephalon from anterior to further posterior with focus on the pallium and 
the anterior commissure. g. Optical sections with focus on the posterior tuberculum in 
the left image and on the hypothalamus in the right image, which is further ventral. h. 
3-dimensional reconstruction of a horizontally performed scan with 85° lateral 
rotation.  
Abbreviations: (ac) anterior commissure, (dienc) diencephalon, (h) hypothalamus, 
(Hc) caudate hypothalamus, (Hi) intermediate hypothalamus, (OT) optic tectum, (p) 
pallium, (PTv) ventral posterior tuberculum, (s) subpallium, (tel) telencephalon 
(dorsal), (vt) ventral thalamus. (After Mueller and Wullimann 2005).  
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Suppl. Fig. 4  Differential activity of hs8a and hs13 in the developing forebrain.  
hs13-regulated GFP is restricted to the medial telencephalon and is distributed widely 
in the preoptic region and hypothalamus, while hs8a has a broad activity in the 
dorsomedial telencephalon and in the thalamus at 1 dpf. With very similar activity of 
the enhancers at 3 dpf, the expression varies again at 5 dpf. Hs8a driven GFP is in the 
medial and lateral telencephalon, while GFP in hs13 transgenic larvae is restricted to 
the medial part including the proliferative zone. Abbreviations: (H) hypothalamus, 





Suppl. Fig. 5  Upregulation of hs8a regulated GFP was quantified by confocal 
microscopy. 
hs2 and hs8a regulated GFP was significantly upregulated in embryos injected with 




Supplemental Fig. 6  hs8a regulated overexpression of arx caused malformation 
of the eyes.  
The eyes grew towards the midline in most of the analyzed specimen. Shown here is 
an example with a severe eye extrusion (marked by the pink arrows). hs8a has a 
strong and broad regulatory activity at 1 dpf in the telencephalon and medial 





Suppl. Fig. 7. Computational prediction of transcription factor binding sites 
(TFBS) overlying the five human ARX enhancers. TFBS were detected according 
to the binding sites predicted by Jaspar (Green) and ConSite (Blue) and matches 
between Jasper and ConSite (Red). TFBS from human and mouse matrices are 
























































































































Suppl. Fig. 7. 
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